Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Liabilities from Discontinued Operations (2017)

Pharma-Bio Serv filings provide 1 years of Liabilities from Discontinued Operations readings, the most recent being 110206.0 for Q4 2017.

  • On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 110206.0 in Q4 2017 year-over-year; TTM through Oct 2017 was 110206.0, a N/A change, with the full-year FY2017 number at 110206.0, changed N/A from a year prior.
  • Liabilities from Discontinued Operations hit 110206.0 in Q4 2017 for Pharma-Bio Serv.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 110206.0 in Q4 2017 to a low of 110206.0 in Q4 2017.